                         SEQUENCE LISTING

<110>  VAXON BIOTECH
       VAXON BIOTECH
       GALLOU, Catherine
       MENEZ-JAMET, Jeanne
 
<120>  IMMUNOGENIC POLYPEPTIDE COMPOSED OF HLA-B7 RESTRICTED TUMOR 
       ANTIGEN-DERIVED OPTIMIZED CRYPTIC PEPTIDES, AND USES THEREOF

<130>  F1788-9WO_VM-sf

<150>  EP 14306187.7
<151>  2014-07-22

<160>  24    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7C1

<400>  1

Ser Pro Arg Leu Gln Leu Ser Asn Gly 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7HN3

<400>  2

Gly Pro Lys His Ser Asp Cys Leu Ala 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7T5

<400>  3

Asp Pro Arg Arg Leu Val Gln Leu Leu 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7M1A6

<400>  4

Gly Pro Arg Ala Leu Ala Glu Thr Ser 
1               5                   


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7M1V6

<400>  5

Gly Pro Arg Ala Leu Ile Glu Thr Ser 
1               5                   


<210>  6
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7M1I6

<400>  6

Gly Pro Arg Ala Leu Val Glu Thr Ser 
1               5                   


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7C1M

<400>  7

Ser Pro Arg Leu Gln Leu Ser Asn Leu 
1               5                   


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7HN3M

<400>  8

Ala Pro Lys His Ser Asp Cys Leu Ala 
1               5                   


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7T5M

<400>  9

Ala Pro Arg Arg Leu Val Gln Leu Leu 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7M1M

<400>  10

Gly Pro Arg Ala Leu Val Glu Thr Leu 
1               5                   


<210>  11
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7C1HN3M

<400>  11

Ser Pro Arg Leu Gln Leu Ser Asn Leu Ala Pro Lys His Ser Asp Cys 
1               5                   10                  15      


Leu Ala 
        


<210>  12
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7HN3C1M

<400>  12

Ala Pro Lys His Ser Asp Cys Leu Ala Ser Pro Arg Leu Gln Leu Ser 
1               5                   10                  15      


Asn Leu 
        


<210>  13
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7C1T5M

<400>  13

Ser Pro Arg Leu Gln Leu Ser Asn Leu Ala Pro Arg Arg Leu Val Gln 
1               5                   10                  15      


Leu Leu 
        


<210>  14
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7T5C1M

<400>  14

Ala Pro Arg Arg Leu Val Gln Leu Leu Ser Pro Arg Leu Gln Leu Ser 
1               5                   10                  15      


Asn Leu 
        


<210>  15
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7C1M1M

<400>  15

Ser Pro Arg Leu Gln Leu Ser Asn Leu Gly Pro Arg Ala Leu Val Glu 
1               5                   10                  15      


Thr Leu 
        


<210>  16
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7M1C1M

<400>  16

Gly Pro Arg Ala Leu Val Glu Thr Leu Ser Pro Arg Leu Gln Leu Ser 
1               5                   10                  15      


Asn Leu 
        


<210>  17
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7HN3T5M

<400>  17

Ala Pro Lys His Ser Asp Cys Leu Ala Ala Pro Arg Arg Leu Val Gln 
1               5                   10                  15      


Leu Leu 
        


<210>  18
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7T5HN3M

<400>  18

Ala Pro Arg Arg Leu Val Gln Leu Leu Ala Pro Lys His Ser Asp Cys 
1               5                   10                  15      


Leu Ala 
        


<210>  19
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7HN3M1M

<400>  19

Ala Pro Lys His Ser Asp Cys Leu Ala Gly Pro Arg Ala Leu Val Glu 
1               5                   10                  15      


Thr Leu 
        


<210>  20
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7M1HN3M

<400>  20

Gly Pro Arg Ala Leu Val Glu Thr Leu Ala Pro Lys His Ser Asp Cys 
1               5                   10                  15      


Leu Ala 
        


<210>  21
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7T5M1M

<400>  21

Ala Pro Arg Arg Leu Val Gln Leu Leu Gly Pro Arg Ala Leu Val Glu 
1               5                   10                  15      


Thr Leu 
        


<210>  22
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  7M1T5M

<400>  22

Gly Pro Arg Ala Leu Val Glu Thr Leu Ala Pro Arg Arg Leu Val Gln 
1               5                   10                  15      


Leu Leu 
        


<210>  23
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide

<400>  23

Ser Pro Arg Leu Gln Leu Ser Asn Leu Ala Pro Arg Arg Leu Val Gln 
1               5                   10                  15      


Leu Leu Gly Pro Arg Ala Leu Val Glu Thr Leu Ala Pro Lys His Ser 
            20                  25                  30          


Asp Cys Leu Ala 
        35      


<210>  24
<211>  45
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide


<220>
<221>  VARIANT
<222>  (10)..(12)
<223>  X = any amino acid or none

<220>
<221>  VARIANT
<222>  (22)..(24)
<223>  X = any amino acid or none

<220>
<221>  VARIANT
<222>  (31)..(36)
<223>  X = any amino acid or none

<400>  24

Ser Pro Arg Leu Gln Leu Ser Asn Leu Xaa Xaa Xaa Ala Pro Arg Arg 
1               5                   10                  15      


Leu Val Gln Leu Leu Xaa Xaa Xaa Gly Pro Arg Ala Leu Val Glu Thr 
            20                  25                  30          


Leu Xaa Xaa Xaa Ala Pro Lys His Ser Asp Cys Leu Ala 
        35                  40                  45  


